Company
Mint Med
Mint Med publishes compounded semaglutide and compounded tirzepatide, from $106 to $145 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from mintmed.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Mint Med
We earn nothing from this link. Mint Med has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Month-to-month, lifetime price, all doses included
first month, including the required fees on record · Month-to-month, lifetime price, all doses included
Terms
| States | 36 states — Arizona, California, Colorado, Connecticut, and 32 more |
|---|
Not yet checked: pharmacy, membership and consultation fee.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Mint Med's own product pages contradict each other on price for the identical drug: the current collection listing prices compounded semaglutide at $106/mo (down to $86/mo on 12-month prepay) and compounded tirzepatide at $145/mo (down to $125/mo on 12-month prepay), but an older/parallel product page (compounded-semaglutide-month-to-month) prices the same compounded semaglutide at $246/mo, another (compounded-semaglutide-1) shows a $133/mo-then-$246/mo starter pack, and the how-it-works promo tile prices compounded tirzepatide at $299 (regular $499) instead of $145. Also a state-count mismatch: the homepage prose says 'Mint Med currently provides services in 35 U.S. states' but the state abbreviation list on the same page enumerates 36 distinct states.
Before you act
Cite this
Treatment Registry. (2026). Mint Med: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/mint-med